LumiThera Announces Top Line Data in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration

SEATTLE, April 7, 2021 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today announced positive findings in its LIGHTSIT... Devices, Ophthalmology LumiThera , photobiomodulation, Age-Related Macular Degeneration
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news